Belpointe Asset Management LLC Acquires 1,122 Shares of Cardinal Health, Inc. $CAH

Belpointe Asset Management LLC lifted its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 40.4% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,901 shares of the company’s stock after acquiring an additional 1,122 shares during the quarter. Belpointe Asset Management LLC’s holdings in Cardinal Health were worth $538,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in CAH. Wellington Management Group LLP boosted its stake in shares of Cardinal Health by 1,666.7% during the 1st quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company’s stock worth $328,470,000 after acquiring an additional 2,249,241 shares during the period. JPMorgan Chase & Co. boosted its stake in shares of Cardinal Health by 40.0% during the 1st quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock worth $575,327,000 after acquiring an additional 1,193,983 shares during the period. GAMMA Investing LLC boosted its stake in shares of Cardinal Health by 17,589.1% during the 1st quarter. GAMMA Investing LLC now owns 964,941 shares of the company’s stock worth $132,940,000 after acquiring an additional 959,486 shares during the period. Zurich Insurance Group Ltd FI boosted its stake in shares of Cardinal Health by 4,935.9% during the 1st quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company’s stock worth $130,434,000 after acquiring an additional 927,950 shares during the period. Finally, Nuveen LLC bought a new stake in Cardinal Health in the 1st quarter valued at $106,065,000. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Stock Performance

NYSE:CAH opened at $152.34 on Friday. The stock has a fifty day moving average price of $154.50 and a 200-day moving average price of $147.79. The company has a market cap of $36.38 billion, a price-to-earnings ratio of 23.62, a PEG ratio of 1.29 and a beta of 0.73. Cardinal Health, Inc. has a fifty-two week low of $106.54 and a fifty-two week high of $168.44.

Cardinal Health (NYSE:CAH) last released its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, beating analysts’ consensus estimates of $2.03 by $0.05. The firm had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The company’s revenue was up .5% compared to the same quarter last year. During the same period in the prior year, the company posted $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Research analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be issued a dividend of $0.5107 per share. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.3%. Cardinal Health’s payout ratio is 31.63%.

Insider Activity at Cardinal Health

In other news, CEO Stephen M. Mason sold 41,575 shares of the business’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the completion of the transaction, the chief executive officer owned 26,085 shares of the company’s stock, valued at approximately $3,881,969.70. The trade was a 61.45% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Jason M. Hollar sold 107,705 shares of the business’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.90, for a total value of $16,037,274.50. Following the transaction, the chief executive officer directly owned 235,901 shares of the company’s stock, valued at $35,125,658.90. This trade represents a 31.35% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 271,676 shares of company stock worth $40,489,525 in the last three months. Insiders own 0.09% of the company’s stock.

Analyst Ratings Changes

Several research firms recently issued reports on CAH. UBS Group restated a “buy” rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Jefferies Financial Group set a $150.00 price target on Cardinal Health in a research note on Tuesday, August 12th. Robert W. Baird boosted their price target on Cardinal Health from $197.00 to $203.00 and gave the company an “outperform” rating in a research note on Wednesday, August 13th. Morgan Stanley restated an “overweight” rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Finally, Leerink Partners reduced their price target on Cardinal Health from $188.00 to $186.00 and set an “outperform” rating for the company in a research note on Tuesday, August 12th. Eleven research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, Cardinal Health currently has an average rating of “Moderate Buy” and a consensus target price of $165.93.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.